MCOLN1 and breast cancer: Genetic depletion and pharmacological inhibition of TRPML1 promote ferroptosis in breast CSCs, reduce their stemness, and enhances the sensitivity of breast cancer cells to conventional chemotherapy drug doxorubicin (DOX).